期刊文献+

深圳市龙华区其他感染性腹泻人群病原构成及耐药情况分析 被引量:5

Analysis of pathogenic composition and drug resistance of other infectious diarrhea populations in Longhua district of Shenzhen city
原文传递
导出
摘要 目的分析深圳市龙华区2017-2018年其他感染性腹泻的病原构成情况,并对病原的耐药情况进行摸查,为更好地预防和控制感染性腹泻在该地区的流行和规范用药提供依据。方法收集辖区哨点医院监测门诊腹泻病例(排除病毒性感染)的粪便标本,开展包括沙门菌、副溶血弧菌、致泻大肠、空肠弯曲菌等致病菌的检测,并对分离到的阳性菌株利用微量肉汤稀释法检测其对30种抗生素的耐药情况。结果检测样本1219份,阳性菌株169份,分离率为13.9%。其中,沙门菌128份,副溶血弧菌38份,其他细菌4份,包括1株EIEC,2株ETEC和1株嗜水气单胞菌。沙门菌的血清型以鼠伤寒沙门菌(45.3%)和肠炎沙门菌(11.7%)为主,副溶血弧菌的血清型以O3K6(76.3%)为主。绝大部分的沙门菌均发生多重耐药,且肠炎沙门菌出现对多粘菌素E耐药的情况,但斯坦利沙门菌只对链霉素耐药,副溶血弧菌仅对头孢唑林耐药。结论鼠伤寒沙门菌仍是龙华区细菌性腹泻的主要致病因子,且绝大多数已经出现多重耐药。副溶血弧菌引起的腹泻病例占比不高,且暂时未发生多重耐药的情况。 Objective In order to better prevent and control the prevalence of infectious diarrhea in this area and provide a basis for the standardized medication of diarrheal diseases,this programme is to analyze the pathogen composition of other infectious diarrhea and investigate the drug resistance of pathogens of Longhua district of Shenzhen city in the year of 2017 to 2018.Methods Fecal specimens of diarrhea cases(excluding viral infections)were collected from sentinel hospitals in the district,and detected for bacteria including Salmonella,Vibrio parahaemolyticus,diarrheogenic Escherichia coli and Campylobacter jejuni.MIC(minimal inhibitory concentration)was used to for susceptibility testing of all isolates.Results1219 samples had been tested and 169 positive strain had been isolated,with the separation rate of about 13.9%;among which,there were 128 Salmonella,38 Vibrio parahaemolyticus,1 EIEC,2 ETEC,and 1 isolated Aeromonashydrophila.The main serotype of Salmonella was typhimurium(45.3%)and enteritidis(11.7%),and the main serotype of Vibrio parahaemolyticus was O3K6(76.3%).Most of the Salmonella had multidrug resistance,and S.enteritidis resistance to polymyxin E,but Stanley only showed resistant to streptomycin.Vibrio parahaemolyticus only showed resistant to cefazolin and ampicillin.Conclusion Salmonella typhimurium was still the main cause of bacterial diarrhea in this region,and most of them had multidrug resistance.The proportion of diarrhea caused by Vibrio parahaemolyticus was not high,and there was no case of multidrug resistance.
作者 张东晓 孙华杰 任燕 林俊香 蔡剑辉 何小媚 李志娇 林启辉 ZHANG Dong xiao;SUN Hua jie;REN Yan;LIN Jun xiang;CAI Jian hui;HE Xiao mei;LI Zhi jiao;LIN Qi hui(Longhua District Center for Disease Control and Prevention,Shenzhen,Guangdong 518109,China)
出处 《热带医学杂志》 CAS 2019年第12期1554-1556,1560,共4页 Journal of Tropical Medicine
基金 深圳市三名工程项目(SZSM201809085).
关键词 其他感染性腹泻 沙门菌 副溶血弧菌 Infectious diarrhea Sallonella Vibrio parahaemolyticus
  • 相关文献

参考文献11

二级参考文献75

  • 1江艳华,姚琳,李风铃,翟毓秀,王联珠.一株多重耐药副溶血性弧菌的耐药分子机制研究[J].食品安全质量检测学报,2014,5(1):77-82. 被引量:3
  • 2王丽丽,徐建国.脉冲场凝胶电泳技术(PFGE)在分子分型中的应用现状[J].疾病监测,2006,21(5):276-279. 被引量:129
  • 3Magiorakos AP,Srinivasan A,Carey RB,et al.Multidrug-resistant,extensively drug-resistant and pandrug-resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect,2012,18 (3):268-281.
  • 4Zhang H,Sun S,Shi W,et al.Serotype,virulence,and genetic traits of foodborne and clinical Vibrio parahaemolyticus isolates in Shanghai,China[J].Foodbome Pathog Dis,2013,10(9):796-804.
  • 5Nair GB,Ramamurthy T,Bhattacharya SK,et al.Global dissemination of Vibrio parahaemolyticus serotype O3 ∶ K6 and its serovariants[J].Clin Microbiol Rev,2007,20(1):39-48.
  • 6Bhuiyan NA,Ansaruzzaman M,Kamruzzaman M,et al.Prevalence of the pandemic genotype of Vibrio parahaemolyticus in Dhaka,Bangladesh,and significance of its distribution across different serotypes[J].J Clin Microbiol,2002,40(1):284-286.
  • 7Okura M,Osawa R,Iguchi A,et al.Genotypic analyses of Vibrio parahaemolyticus and development of a pandemic group-specific multiplex PCR assay[J].J Clin Microbiol,2003,41 (10):4676-4682.
  • 8Nasu H,Iida T,Sugahara T,et al.A filamentous phage associated with recent pandemic Vibrio parahaemolyticus O3 ∶ K6 strains[J].J Clin Microbiol,2000,38 (6):2156-2161.
  • 9Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. CLSI document M100-S25 [ S ] . Wayne, Pennsylvania:CLSI, 2015.
  • 10Leclercq R, Canton R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect,2013,19 ( 2 ) : 141-160.

共引文献177

同被引文献61

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部